Aberrant expression of TUBA1C has been reported in several malignancies, including pancreatic ductal adenocarcinoma 74, breast cancer 75 and bladder urothelial carcinoma 76. The gene discussed is TUBA1C; the disease is bladder transitional cell carcinoma.